Prescriptions for vitamin D among patients taking antiresorptive agents in Canada

Current Medical Research and Opinion

Volumn 23, Issue 6, 2007, Pages 1473-1480

  Hanley, David A ^a   Zhang, Qiaoyi ^b   Meilleur, Marie Claude ^c   Mavros, Panagiotis ^b   Sen, Shuvayu S ^b,d  

^a UNIVERSITY OF CALGARY   (Canada)

^b MERCK RESEARCH LABORATORIES   (United States)

^c MERCK FROSST CENTRE FOR THERAPEUTIC RESEARCH   (Canada)

^d Outcomes Research   (United States)

Author keywords

Antiresorptive medications; Osteoporosis; Vitamin D; Vitamin D deficiency

Indexed keywords

ALENDRONIC ACID; ALFACALCIDOL; BISPHOSPHONIC ACID DERIVATIVE; CALCITRIOL; COLECALCIFEROL; DOXERCALCIFEROL; ERGOCALCIFEROL; ESTROGEN; ETIDRONIC ACID; IBANDRONIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; RALOXIFENE; RISEDRONIC ACID; STEROID; VITAMIN D;

AGED; ARTICLE; CANADA; DRUG USE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOPOROSIS; PRESCRIPTION; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS; TREATMENT DURATION; VITAMIN D DEFICIENCY;

AGED; AGED, 80 AND OVER; BONE DENSITY CONSERVATION AGENTS; CANADA; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; OSTEOPOROSIS; PRESCRIPTIONS, DRUG; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VITAMIN D;

EID: 34347236499     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079907X188198     Document Type: Article

References (34)

1. Erben RG. Vitamin D analogs and bone. J Musculoskelet Neuronal Interact 2001;2:59-69
2. Montero-Odasso M, Duque G. Vitamin D in the aging musculoskeletal system: an authentic strength preserving hormone. Mol Aspects Med 2005;26:203-19
3. Bischoff-Ferrari HA, Conzelmann M, Stahelin HB, et al. Is fall prevention by vitamin D mediated by a change in postural or dynamic balance? Osteoporos Int 2006;17:656-63
4. Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC, et al. Effect of vitamin D on falls: a meta-analysis. JAMA 2004;291:1999-2006
5. Staud R. Vitamin D: more than just affecting calcium and bone. Curr Rheumatol Rep 2005;7:356-64
6. Woolf AD, Pfleger B. Burden of major musculoskeletal conditions. Bull World Health Organ 2003;81:646-56
7. Blake AJ, Morgan K, Bendall MJ, et al. Falls by elderly people at home: prevalence and associated factors. Age Ageing 1988;17:365-72
8. Cummings SR, Nevitt MC. Falls. N Engl J Med 1994;331:872-3
9. Melton LJ III. Who has osteoporosis? A conflict between clinical and public health perspectives. J Bone Miner Res 2000;15:2309-14
10. Melton LJ III. Adverse outcomes of osteoporosis fractures in the general population. J Bone Miner Res 2003;18:1139-41
11. Cummings SR, Melton LJ III. Epidemiology and outcomes of osteoporotic fractures. Lancet 2002;359:1761-7
12. Malavolta N, Pratelli L, Frigato M, et al. The relationship of vitamin D status to bone mineral density in an Italian population of postmenopausal women. Osteoporos Int 2005;16:1691-7
13. Bischoff-Ferrari HA, Dietrich T, Orav EJ, et al. Positive association between 25-hydroxy vitamin D levels and bone mineral density: a population-based study of younger and older adults. Am J Med 2004;116:634-9
14. von Mühlen DG, Greendale GA, Garland CF, et al. Vitamin D, parathyroid hormone levels and bone mineral density in community-dwelling older women: the Rancho Bernardo Study. Osteoporos Int 2005;16:1721-6
15. Larsen ER, Mosekilde L, Foldspang A. Vitamin D and calcium supplementation prevents osteoporotic fractures in elderly community dwelling residents: a pragmatic population-based 3-year intervention study. J Bone Miner Res 2004;19:370-8
16. MacLaughlin J, Holick MF. Aging decreases the capacity of human skin to produce vitamin D3. J Clin Invest 1985;76:1536-8
17. Holick MF, Matsuoka LY, Wortsman J. Age, vitamin D, and solar ultraviolet. Lancet 1989;2:1104-5
18. Koster JC, Hackeng WH, Mulder H. Diminished effect of etidronate in vitamin D deficient osteopenic postmenopausal women. Eur J Clin Pharmacol 1996;51:145-7
19. Holick MF. The vitamin D epidemic and its health consequences. J Nutr 2005;135:2739S-48S
20. Holick MF. High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc 2006;81:353-73
21. Simonelli C, Weiss TW, Morancey J, et al. Prevalence of vitamin D inadequacy in a minimal trauma fracture population. Curr Med Res Opin 2005;21:1069-74
22. Moniz C, Dew T, Dixon T. Prevalence of vitamin D inadequacy in osteoporotic hip fracture patients in London. Curr Med Res Opin 2005;21:1891-4
23. Solomon DH, Morris C, Cheng H, et al. Medication use patterns for osteoporosis: an assessment of guidelines, treatment rates, and quality improvement interventions. Mayo Clin Proc 2005;80:194-202
24. Huybrechts KF, Ishak KJ, Caro JJ. Assessment of compliance with osteoporosis treatment and its consequences in a managed care population. Bone 2006;38:922-8
25. Bayly JR, Hollands RD, Riordan-Jones SE, et al. Prescribed vitamin D and calcium preparations in patients treated with bone remodelling agents in primary care: a report of a pilot study. Curr Med Res Opin 2006;22:131-7
26. Ness J, Aronow WS, Newkirk E, et al. Underutilization of calcium and vitamin D by older adults in a large general internal medicine practice. Am J Ther 2005;12:113-6
27. National Institutes of Health. Osteoporosis prevention, diagnosis, and therapy. JAMA 2001;285:785-95
28. Kamel HK. Underutilization of calcium and vitamin D supplements in an academic long-term care facility. J Am Med Dir Assoc 2004;5:98-100
29. Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther 2001;23:1296-1310
30. Cramer JA, Amonkar MM, Hebborn A, et al. Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis. Curr Med Res Opin 2005;21:1453-60
31. Antoniucci DM, Vittinghoff E, Blackwell T, et al. Vitamin D insufficiency does not affect bone mineral density response to raloxifene. J Clin Endocrinol Metab 2005;90:4566-72
32. Heaney RP, Draper MW. Raloxifene and estrogen: comparative bone-remodeling kinetics. J Clin Endocrinol Metab 1997;82:3425-9
33. Grant AM, Avenell A, Campbell MK, et al. Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial. Lancet 2005;365:1621-8
34. Porthouse J, Cockayne S, King C, et al. Randomised controlled trial of calcium and supplementation with cholecalciferol (vitamin D3) for prevention of fractures in primary care. BMJ 2005;330:1003